Influence of a chronic new potential antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole(FS32) and its N-desmethylated compound(FS97): treatment on monoaminergic receptor sensitivity in the rat brain.
D000818:Animals; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D003891:Desipramine / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D007191:Indazoles / Q000494:pharmacology*; D008297:Male; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D011985:Receptors, Serotonin / Q000187:drug effects*
D007191:Indazoles; D011720:Pyrazoles; D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; C020952:1-(3-(dimethylamino)propyl)-5-methyl-3- phenyl-1H-indazole; C025243:1-(3-(methylamino)-propyl)-5-methyl-3-phenyl-1H-indazole; D007099:Imipramine; D003891:Desipramine